- Home
- ASND vs CWAN Comparison
ASND vs CWAN Comparison
Compare ASND & CWAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASND
- CWAN
- Stock Information
- Founded
- ASND 2006
- CWAN 2004
- Country
- ASND Denmark
- CWAN United States
- Employees
- ASND N/A
- CWAN N/A
- Industry
- ASND Biotechnology: Pharmaceutical Preparations
- CWAN Computer Software: Prepackaged Software
- Sector
- ASND Health Care
- CWAN Technology
- Exchange
- ASND Nasdaq
- CWAN Nasdaq
- Market Cap
- ASND 9.1B
- CWAN 7.3B
- IPO Year
- ASND 2015
- CWAN 2021
- Fundamental
- Price
- ASND $158.14
- CWAN $22.30
- Analyst Decision
- ASND Strong Buy
- CWAN Buy
- Analyst Count
- ASND 15
- CWAN 9
- Target Price
- ASND $202.00
- CWAN $33.89
- AVG Volume (30 Days)
- ASND 562.0K
- CWAN 2.4M
- Earning Date
- ASND 05-05-2025
- CWAN 04-30-2025
- Dividend Yield
- ASND N/A
- CWAN N/A
- EPS Growth
- ASND N/A
- CWAN N/A
- EPS
- ASND N/A
- CWAN 1.68
- Revenue
- ASND $376,478,932.00
- CWAN $451,803,000.00
- Revenue This Year
- ASND $61.43
- CWAN $21.92
- Revenue Next Year
- ASND $73.07
- CWAN $19.11
- P/E Ratio
- ASND N/A
- CWAN $13.30
- Revenue Growth
- ASND 36.34
- CWAN 22.72
- 52 Week Low
- ASND $111.09
- CWAN $15.62
- 52 Week High
- ASND $169.37
- CWAN $35.71
- Technical
- Relative Strength Index (RSI)
- ASND 55.10
- CWAN 36.24
- Support Level
- ASND $153.17
- CWAN $21.13
- Resistance Level
- ASND $165.42
- CWAN $23.55
- Average True Range (ATR)
- ASND 10.68
- CWAN 1.33
- MACD
- ASND 1.20
- CWAN -0.08
- Stochastic Oscillator
- ASND 82.40
- CWAN 20.12
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
About CWAN Clearwater Analytics Holdings Inc.
Clearwater Analytics Holdings Inc provides a SaaS solution for automated investment data aggregation, reconciliation, accounting and reporting services to insurers, investment managers, corporations, institutional investors and government entities. It earns revenue from providing access to its SaaS platform to customers, services that support the implementation on the SaaS platform, selling perpetual and term-based software licenses and providing maintenance and support and professional services under contracts with customers. The majority of the revenue is earned in the United States.